 NEW YORK--BUSINESS WIRE-- FederalSecuritiesLaws--Bragar Eagel Squire, P.C., a nationally recognized shareholder rights law firm, announces that the Shareholder Class Action Against Myriad Genetics, Inc. NASDAQ: MYGN has survived the motions to dismiss in the pending securities class action and may face damages. Long-term investors are encouraged to contact the firm. According to the securities class action complaint, throughout the Class Period defendants made materially false and misleading statements regar 